Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Basilea Pharmaceutica AG: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

07 May 2016 Reuters Investment Profile 12 $20.00

Basilea Pharmaceutica AG: Downgraded to Risky

17 May 2016 Sadif Analytics Prime 3 $10.00

Basilea Pharmaceutica AG (BSLN) - Financial Analysis Review

Basilea Pharmaceutica AG (BSLN) - Financial Analysis Review Summary Basilea Pharmaceutica AG (Basilea) is a pharmaceutical co...

16 May 2016 GlobalData 49 $300.00

Wright Investors Service Comprehensive Report for Basilea Pharmaceutica Limited

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

23 Apr 2016 Wright Reports 56 $75.00

BASILEA PHARMACEUTICA - ZEVTERA US DEVELOPMENT FULL STEAM AHEAD

Basilea has announced that BARDA, a division of the US Department of Health & Human Services Office, has awarded a contract o...

22 Apr 2016 Edison Investment Research 5 $10.00

BASILEA PHARMACEUTICA - RIDING THE CREST OF THE NOVEL ANTIMICROBIAL WAVE

Basilea is one of the few standalone European companies focused on developing novel antimicrobial drugs. It has two approved ...

23 Mar 2016 Edison Investment Research 16 $10.00

Is Basilea Pharmaceutica AG Worth a Higher Bid?

22 Mar 2016 Sadif Analytics Prime 12 $25.00

Basilea Pharmaceutica AG (BSLN) - Financial Analysis Review

Basilea Pharmaceutica AG (BSLN) - Financial Analysis Review Summary Basilea Pharmaceutica AG (Basilea) is a pharmaceutical co...

17 Mar 2016 GlobalData 52 $300.00

Basilea Pharmaceutica AG: Upgraded to Below Average

15 Mar 2016 Sadif Analytics Prime 3 $10.00

BSLN.S - Event Transcript of Basilea Pharmaceutica AG conference call, Feb. 29, 2016 / 10:00AM ET

Edited Event Transcript of BSLN.S conference call, Feb. 29, 2016 / 10:00AM ET Boston, Feb 29, 2016 (Thomson StreetEvent...

29 Feb 2016 Thomson Reuters StreetEvents 10 $75.00